Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1159/000511713 http://scihub22266oqcxt.onion/10.1159/000511713 33017834!7573894!33017834     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       ORL+J+Otorhinolaryngol+Relat+Spec 2021 ; 83 (1): 47-51 Nephropedia Template TP {{tp|p=33017834|t=2021. Management of a Unique Sinonasal Undifferentiated Carcinoma Subtype in the Era of SARS-CoV-2 |pdf=|usr=}}{{33017834}} gab.com Text Management of a Unique Sinonasal Undifferentiated Carcinoma Subtype in the Era of SARS-CoV-2 JO: ORL J Otorhinolaryngol Relat Spec http://www.kidney.de/pget.php?&tw=1&pmid=33017834 #FOAvip The novel coronavirus (SARS-CoV-2) pandemic has influenced the timeliness of care for patients with both common and rare conditions, particularly those affecting high-risk operative sites such as the upper aerodigestive tract. Sinonasal undifferentiated carcinoma (SNUC) represents a rare malignancy of the sinonasal tract, a unique subset of which has never been previously reported in the otolaryngology literature and is characterized by inactivation of the SMARCB (INI-1) tumor suppressor gene. This subtype exhibits a particularly poor prognosis and is characterized pathologically by its rhabdoid appearance. Here we present the case of an individual who was diagnosed with a sinonasal mass during the SARS-CoV-2 pandemic, which was ultimately found to be SMARCB (INI-1)-deficient sinonasal carcinoma. Advanced imaging was deferred in the interest of limiting the patient's exposure to the virus, and expedited operative management was performed which facilitated prompt referral for adjuvant chemoradiation. The SARS-CoV-2 pandemic presents unique challenges, but the work-up of high-risk lesions must be prioritized; this continues to be paramount as SARS-CoV-2 resurges in many cities across the USA. Twit Text FOAVip Management of a Unique Sinonasal Undifferentiated Carcinoma Subtype in the Era of SARS-CoV-2 ????ORL J Otorhinolaryngol Relat Spec http://www.kidney.de/pget.php?&tw=1&pmid=33017834 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33017834 #FOAvip English Wikipedia <ref>{{Cite pmid|33017834}}</ref> Management of a Unique Sinonasal Undifferentiated Carcinoma Subtype in the Era of SARS-CoV-2 #MMPMID33017834 Douglas JE; Kaufman AC; Rajasekaran K ORL J Otorhinolaryngol Relat Spec 2021[]; 83 (1): 47-51 PMID33017834show ga The novel coronavirus (SARS-CoV-2) pandemic has influenced the timeliness of care for patients with both common and rare conditions, particularly those affecting high-risk operative sites such as the upper aerodigestive tract. Sinonasal undifferentiated carcinoma (SNUC) represents a rare malignancy of the sinonasal tract, a unique subset of which has never been previously reported in the otolaryngology literature and is characterized by inactivation of the SMARCB (INI-1) tumor suppressor gene. This subtype exhibits a particularly poor prognosis and is characterized pathologically by its rhabdoid appearance. Here we present the case of an individual who was diagnosed with a sinonasal mass during the SARS-CoV-2 pandemic, which was ultimately found to be SMARCB (INI-1)-deficient sinonasal carcinoma. Advanced imaging was deferred in the interest of limiting the patient's exposure to the virus, and expedited operative management was performed which facilitated prompt referral for adjuvant chemoradiation. The SARS-CoV-2 pandemic presents unique challenges, but the work-up of high-risk lesions must be prioritized; this continues to be paramount as SARS-CoV-2 resurges in many cities across the USA. |Biopsy[MESH] |COVID-19/*epidemiology[MESH] |Carcinoma/*diagnosis/pathology/*surgery[MESH] |Chemoradiotherapy, Adjuvant[MESH] |Diagnosis, Differential[MESH] |Endoscopy[MESH] |Female[MESH] |Humans[MESH] |Maxillary Sinus Neoplasms/*diagnosis/pathology/*surgery[MESH] |Middle Aged[MESH] |SARS-CoV-2[MESH]Management of a Unique Sinonasal Undifferentiated Carcinoma Subtype in(epmc).pdf DeepDyve Pubget Overpricing